JP2024510501A5 - - Google Patents

Info

Publication number
JP2024510501A5
JP2024510501A5 JP2023557349A JP2023557349A JP2024510501A5 JP 2024510501 A5 JP2024510501 A5 JP 2024510501A5 JP 2023557349 A JP2023557349 A JP 2023557349A JP 2023557349 A JP2023557349 A JP 2023557349A JP 2024510501 A5 JP2024510501 A5 JP 2024510501A5
Authority
JP
Japan
Prior art keywords
indocyanine green
composition according
histidine
weight ratio
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023557349A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024510501A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/056446 external-priority patent/WO2022194734A1/en
Publication of JP2024510501A publication Critical patent/JP2024510501A/ja
Publication of JP2024510501A5 publication Critical patent/JP2024510501A5/ja
Pending legal-status Critical Current

Links

JP2023557349A 2021-03-17 2022-03-14 インドシアニングリーンの安定な処方物 Pending JP2024510501A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21305324.2 2021-03-17
EP21305324 2021-03-17
PCT/EP2022/056446 WO2022194734A1 (en) 2021-03-17 2022-03-14 Stable formulations of indocyanine green

Publications (2)

Publication Number Publication Date
JP2024510501A JP2024510501A (ja) 2024-03-07
JP2024510501A5 true JP2024510501A5 (enExample) 2025-02-26

Family

ID=75302476

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023557349A Pending JP2024510501A (ja) 2021-03-17 2022-03-14 インドシアニングリーンの安定な処方物

Country Status (7)

Country Link
US (1) US20240156991A1 (enExample)
EP (1) EP4308076B1 (enExample)
JP (1) JP2024510501A (enExample)
CN (1) CN117098532A (enExample)
BR (1) BR112023018929A2 (enExample)
ES (1) ES3042376T3 (enExample)
WO (1) WO2022194734A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4308082A1 (en) * 2021-03-17 2024-01-24 Provepharm Life Solutions Stable formulations of indocyanine green

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08509260A (ja) * 1993-04-20 1996-10-01 マリンクロット・メディカル・インコーポレイテッド 電圧感受性染料の安定化
FR2710060B1 (fr) 1993-09-17 1995-11-17 Rech Biolog Et Procédé de préparation de benz[e]indoles substitués de pureté élevée et leurs sels alcalins.
US6944493B2 (en) * 1999-09-10 2005-09-13 Akora, Inc. Indocyanine green (ICG) compositions and related methods of use
CA2635975A1 (en) * 2006-01-04 2007-07-12 Do-Coop Technologies Ltd. Compositions and methods for enhancing in-vivo uptake of pharmaceutical agents
DE102007030403A1 (de) 2007-06-29 2009-01-08 Universität Bielefeld Verfahren zur Verbesserung der Photostabilität von Fluoreszenzfarbstoffen
CN103301482B (zh) 2013-06-27 2014-12-17 深圳先进技术研究院 两亲性三嵌段聚多肽载icg胶束及其制备方法
JP6623479B2 (ja) 2015-02-08 2019-12-25 トンリ・バイオメディカル・カンパニー・リミテッド 脂質ナノ粒子及びその使用
CA3021809A1 (en) * 2015-05-11 2016-11-17 Dicronis Sagl Compositions for circulatory system visualization
DK3383436T3 (da) 2015-12-01 2023-11-20 Dishman Carbogen Amcis Ltd Forbedret fremgangsmåde til fremstilling af indocyaningrønt
US20190337896A1 (en) 2018-05-02 2019-11-07 Biophore India Pharmaceuticals Pvt. Ltd. PROCESS FOR THE PREPARATION OF SODIUM 4-(2-((1E,3E,5E,7Z)-7-(1,1-DIMETHYL-3-(4-SULFONATOBUTYL)-1H-BENZO[e]INDOL-2(3H)-YLIDENE) HEPTA-1,3,5-TRIENYL)-1,1-DIMETHYL-1H-BENZO[e]INDOLIUM-3-YL) BUTANE-1-SULFONATE (INDOCYANINE GREEN)
WO2020240514A1 (en) 2019-05-30 2020-12-03 Leiutis Pharmaceuticals Pvt, Ltd. Stable formulations of indocyanine green

Similar Documents

Publication Publication Date Title
CA1052270A (en) Oxytetracycline solution for parenteral peroral and local administration and processes for the production thereof
JPS6021570B2 (ja) ド−パ類の高濃度製剤の製法
JP2004067682A (ja) 抗生物質活性を有する薬学的組成物
JP2015028043A (ja) S−アデノシルメチオニンの安定な塩およびその調製のための方法
KR102044734B1 (ko) 캡슐 제형
JPWO2018221487A1 (ja) エリブリンまたはその薬剤学的に許容される塩を含む注射剤
JP2003104887A (ja) 光に安定なアラニジピン含有組成物
PT1928459E (pt) Preparação de libertação retardada na forma de comprimidos contendo cinarizina e dimenidrinato contra a vertigem
JP2024510302A5 (enExample)
WO2017150511A1 (ja) 液状医薬製剤
JP2019502751A5 (enExample)
JP2024510500A5 (enExample)
JP2001233766A (ja) プラバスタチンナトリウムの錠剤
PT695544E (pt) Capsulas de gelatina dura resistentes a desnaturacao e sua producao
ES2247134T3 (es) Procedimiento para secar amoxicilina.
JP2010047482A (ja) エダラボン注射液
JPH05229943A (ja) 脳保護剤
PT1622587E (pt) Preparaã†o farmac—utica sëlida contendo sais de levotiroxina e/ou liotironina
JPH0144172B2 (enExample)
RU2238720C1 (ru) Фармацевтический водный раствор для инъекций
ITMI20111452A1 (it) Soluzione basica di acido alfa-lipoico e suoi usi
JPH02193925A (ja) 膣坐剤
JPH0616537A (ja) 水難溶性薬物の医薬組成物
JP2885668B2 (ja) テプレノン製剤
KR960004018B1 (ko) L-글루타민과 수용성아줄렌 복합 항궤양용 제제의 안정화 방법